AYOXXA @ 37th Annual J.P. Morgan Healthcare Conference
AYOXXA introduces its innovative LUNARIS™ platform to executives from internationally renowned pharmaceutical and biotech companies as well as to members of the investment community, meeting at the largest and most informative healthcare investment symposium in the industry from January 7 - 10, 2019 at the Westin St. Francis Hotel in San Francisco, California.
“We believe this is an ideal time to present AYOXXA to interested investors and pharmaceutical executives as the Company has made major progress in executing its strategy to become an emerging player for multiplex protein analysis in translational science, one of the fastest growing fields in molecular research,” said Rodney Turner, CEO of AYOXXA.
“2019 will be an important year for AYOXXA as we will be focusing on further building our commercial marketing traction as well as finding the right partners for clinical projects and new panel developments. We are delighted that multiple partners from the pharmaceutical and diagnostic space have chosen the LUNARIS™ System as their new standard for multiplex analysis in various segments.” Wolfgang Kintzel, Co-CEO of AYOXXA added.
Rodney Turner, AYOXXA’s CEO and Wolfgang Kintzel, Co-CEO, will both be available for one-on-one meetings over the course of the conference.
Parties interested in meeting with AYOXXA at J.P. Morgan are requested to contact Kirsten Sievert at firstname.lastname@example.org.